Category: Medication
Pharmaceutical Companies Increase Drug Prices in January 2024
--- Pharmaceutical companies have raised the list prices of 775 brand-name drugs in the early months of 2024, with a median increase of 4.5 percent,[more...]
Possible Connection Between GLP-1 Drugs and Suicidal Thoughts: FDA Investigation Continues
The Food and Drug Administration (FDA) recently announced that it has not found compelling evidence linking GLP-1 drugs, including semaglutide, to suicidal thoughts or behaviors.[more...]
The Dark Side of Ozempic: Lawsuits and Allegations of Life-Changing Side Effects
A woman has come forward with alarming allegations about the side effects she allegedly suffered after taking the weight loss drug, Ozempic. She claims that[more...]
The Dark Side of Asthma Medication: Montelukast’s Potential Link to Mental Health Issues
Montelukast, a prescription medication used to control asthma symptoms and relieve seasonal allergies, has been under increased scrutiny due to its potential mental health side[more...]
FDA Finds No Evidence That Weight-Loss Drugs Cause Suicidal Thoughts
The U.S. Food and Drug Administration (FDA) recently conducted a preliminary review of the side effects of several popular drugs used to treat diabetes and[more...]
Designer Xanax: A Deadly Trend on the Rise
Amidst the ongoing battle against drug abuse and opioid addiction, health officials in the United States have raised concerns about the growing prevalence of designer[more...]
Study finds no evidence of increased suicidal thoughts linked to Ozempic and Wegovy
A recent study published in Nature Medicine has reported that there is no evidence linking an increased risk of suicidal thoughts to the use of[more...]
Asthma Inhaler Flovent Discontinued: What Patients Need to Know
In a recent development, pharmaceutical manufacturer GlaxoSmithKline (GSK) has discontinued the production of the asthma inhaler Flovent, which has been one of the most widely-used[more...]
Discontinuation of Flovent Inhaler Sparks Concern among Asthma Patients and Physicians
--- Starting January 1, 2024, asthma patients in the United States face the disappearance of the branded asthma inhaler, Flovent, from pharmacy shelves. The discontinuation[more...]
Patients Face Challenges as GSK Discontinues Asthma Inhaler Flovent
Patients who rely on the asthma inhaler Flovent will soon face challenges as GlaxoSmithKline (GSK) discontinues the branded medication and replaces it with an authorized[more...]